Report Detail
Global Genitourinary Drugs Market Insights, Forecast to 2025
- RnM3421704 |
- 15 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.
The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pipeline drugs are expected to widen the scope for growth in the future.
The global Genitourinary Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Genitourinary Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Genitourinary Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Genitourinary Drugs in these regions.
This research report categorizes the global Genitourinary Drugs market by top players/brands, region, type and end user. This report also studies the global Genitourinary Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis AG
Genentech
Market size by Product
Urologicals
Hormonal Therapy
Gynecological
Anti-infectives
Market size by End User
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases
Interstitial Cystitis
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Genitourinary Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Genitourinary Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Genitourinary Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Genitourinary Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Genitourinary Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Genitourinary Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Genitourinary Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Genitourinary Drugs Market Size Growth Rate by Product
- 1.4.2 Urologicals
- 1.4.3 Hormonal Therapy
- 1.4.4 Gynecological
- 1.4.5 Anti-infectives
- 1.5 Market by End User
- 1.5.1 Global Genitourinary Drugs Market Size Growth Rate by End User
- 1.5.2 Prostate Cancer
- 1.5.3 Ovarian Cancer
- 1.5.4 Bladder Cancer
- 1.5.5 Cervical Cancer
- 1.5.6 Renal Cancer
- 1.5.7 Erectile Dysfunction
- 1.5.8 Urinary Tract Infections
- 1.5.9 Urinary Incontinence & Overactive Bladder
- 1.5.10 Sexually Transmitted Diseases
- 1.5.11 Interstitial Cystitis
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Genitourinary Drugs Market Size
- 2.1.1 Global Genitourinary Drugs Revenue 2014-2025
- 2.1.2 Global Genitourinary Drugs Sales 2014-2025
- 2.2 Genitourinary Drugs Growth Rate by Regions
- 2.2.1 Global Genitourinary Drugs Sales by Regions
- 2.2.2 Global Genitourinary Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Genitourinary Drugs Sales by Manufacturers
- 3.1.1 Genitourinary Drugs Sales by Manufacturers
- 3.1.2 Genitourinary Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Genitourinary Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Genitourinary Drugs Revenue by Manufacturers
- 3.2.1 Genitourinary Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Genitourinary Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Genitourinary Drugs Price by Manufacturers
- 3.4 Genitourinary Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Genitourinary Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Genitourinary Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Genitourinary Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Genitourinary Drugs Sales by Product
- 4.2 Global Genitourinary Drugs Revenue by Product
- 4.3 Genitourinary Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Genitourinary Drugs Breakdown Data by End User
6 North America
- 6.1 North America Genitourinary Drugs by Countries
- 6.1.1 North America Genitourinary Drugs Sales by Countries
- 6.1.2 North America Genitourinary Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Genitourinary Drugs by Product
- 6.3 North America Genitourinary Drugs by End User
7 Europe
- 7.1 Europe Genitourinary Drugs by Countries
- 7.1.1 Europe Genitourinary Drugs Sales by Countries
- 7.1.2 Europe Genitourinary Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Genitourinary Drugs by Product
- 7.3 Europe Genitourinary Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Genitourinary Drugs by Countries
- 8.1.1 Asia Pacific Genitourinary Drugs Sales by Countries
- 8.1.2 Asia Pacific Genitourinary Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Genitourinary Drugs by Product
- 8.3 Asia Pacific Genitourinary Drugs by End User
9 Central & South America
- 9.1 Central & South America Genitourinary Drugs by Countries
- 9.1.1 Central & South America Genitourinary Drugs Sales by Countries
- 9.1.2 Central & South America Genitourinary Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Genitourinary Drugs by Product
- 9.3 Central & South America Genitourinary Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Genitourinary Drugs by Countries
- 10.1.1 Middle East and Africa Genitourinary Drugs Sales by Countries
- 10.1.2 Middle East and Africa Genitourinary Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Genitourinary Drugs by Product
- 10.3 Middle East and Africa Genitourinary Drugs by End User
11 Company Profiles
- 11.1 Novartis AG
- 11.1.1 Novartis AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis AG Genitourinary Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis AG Genitourinary Drugs Products Offered
- 11.1.5 Novartis AG Recent Development
- 11.2 Genentech
- 11.2.1 Genentech Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Genentech Genitourinary Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Genentech Genitourinary Drugs Products Offered
- 11.2.5 Genentech Recent Development
12 Future Forecast
- 12.1 Genitourinary Drugs Market Forecast by Regions
- 12.1.1 Global Genitourinary Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Genitourinary Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Genitourinary Drugs Market Forecast by Product
- 12.2.1 Global Genitourinary Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Genitourinary Drugs Revenue Forecast by Product 2019-2025
- 12.3 Genitourinary Drugs Market Forecast by End User
- 12.4 North America Genitourinary Drugs Forecast
- 12.5 Europe Genitourinary Drugs Forecast
- 12.6 Asia Pacific Genitourinary Drugs Forecast
- 12.7 Central & South America Genitourinary Drugs Forecast
- 12.8 Middle East and Africa Genitourinary Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Genitourinary Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Genitourinary Drugs . Industry analysis & Market Report on Genitourinary Drugs is a syndicated market report, published as Global Genitourinary Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Genitourinary Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
